Powerful ScienceMeaningful MedicinesChanging Lives 89bio is a clinical-stage biopharma company focused on the development and commercialization of innovative therapies for patients with non-alcoholic steatohepatitis (NASH), severe hypertrigly-ceridemia...

Biotechnology

89bio

89bio's headquarters in San Francisco, CA, United States

Melissa Abel

Amanda Kurihara

Ryan Martins

Francis Sarena

Quoc Le-Nguyen

Hank Mansbach

Toni Bransford

Kristin Lichti-Kaiser

Wenyan Wang

Mms Rebecca Crank Pa-C (Becky)

Laura Healy

Roger Lee

Shaji Joseph

Shibao Feng

Michael Baldwin

Annie Chang

Merav Barki

Shiva Natarajan

Leslie Fok

Trisha Colton

Graciela Corona

Joanna Montgomery

Nancy Vinh

Rotem Dror

Lota Zoth

Michael Hayden

Charles A. McWherter

Martin Babler

Kathy Laporte

Steven Altschuler

Derek Dirocco

The Clinical and Medical Team at 89bio is responsible for designing and conducting clinical trials, ensuring regulatory compliance, and developing medical strategies for innovative therapies targeted at non-alcoholic steatohepatitis (NASH) and severe hypertriglyceridemia. They oversee clinical operations, manage medical writing, analyze biostatistical data, and liaise with regulatory bodies to advance the company's drug development pipeline effectively and safely.

Clinical and Medical Team

This department oversees the planning, management, and execution of clinical trials and related operations.

Clinical Operations

This department oversees the operations and quality assurance processes related to chemistry, manufacturing, and controls.

CMC Operations

The Leadership Team at 89bio drives the strategic vision and operational execution of the company, ensuring alignment across critical functions such as research and development, commercial strategy, regulatory affairs, and finance. This team collaborates to foster innovation and advance the development of breakthrough therapies for patients suffering from conditions like NASH and severe hypertriglyceridemia, while also nurturing a strong company culture.

Leadership Team

The Directors team at 89bio is responsible for guiding the company's strategic direction, overseeing clinical development programs, ensuring corporate governance, and making high-level decisions regarding commercialization efforts. They also play a key role in risk management, financial oversight, and fostering impactful partnerships to advance innovative therapies for patients.

Directors

The Finance and Accounting Team at 89bio is responsible for managing the company's financial health, overseeing budgeting and forecasting, ensuring regulatory compliance, and providing strategic financial insights to support the development and commercialization of innovative therapies for NASH and severe hypertriglyceridemia.

Finance and Accounting Team

89bio

Org chart

Board & advisors

Teams

Clinical and Medical Team

Clinical Operations

CMC Operations

Leadership Team

Directors

Finance and Accounting Team

Offices

89bio

Org chart

Board & advisors

Teams

Clinical and Medical Team

Clinical Operations

CMC Operations

Leadership Team

Directors

Finance and Accounting Team

Offices

Related companies